TORONTO, ON / ACCESS Newswire / October 17, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that…
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned…
HENDERSON, Nev.--(BUSINESS WIRE)--Roseman University of Health Sciences and PDS Health® celebrated the dedication and ribbon-cutting of the new Thorne Clinic…
The first of two Black Book investor briefs identifies the health-tech categories demonstrating pilot-to-scale momentum and early indicators of exit-level…
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services BENGALURU and HYDERABAD, India, Oct. 17, 2025 /PRNewswire/ --…
Powered by the PLAiTO™ AI Intelligence Engine Two New Executives Named to Spearhead Growth TIBURON, Calif., Oct. 17, 2025 /PRNewswire/…
SAN JOSE, CA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions,…
MESA, ARIZONA / ACCESS Newswire / October 17, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today outlines the tremendous…
BELLINGHAM, MASSACHUSETTS / ACCESS Newswire / October 17, 2025 / Medical Component Specialists (MCS), a leading contract manufacturer serving medical…
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 17, 2025 / CNN spotlighted Dr. Michael Everest, Chief Academic Officer and…